This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


A novel database aimed at promoting drug design using cyclic peptides

CycPeptMPDB: A database aimed at promoting drug design using cyclic peptides
Credit: Professor Yutaka Akiyama

CycPeptMPDB, a novel database created by Tokyo Tech researchers, focuses on the membrane permeability of cyclic peptides and could accelerate the development of drugs based on these promising compounds. This database was created by gathering published information on thousands of cyclic peptides and organizing it neatly in an online-accessible platform. Thanks to its search and visualization capabilities, CycPeptMPDB could pave the way to new computational and machine learning methods for screening and designing drugs with cyclic peptides.

One of the greatest challenges in modern drug design is to find compounds that satisfy somewhat contradictory requirements—they need to be small enough to permeate human cell membranes, while being large enough to target various protein surfaces and protein–protein interactions. This is a fine balance to achieve—if the compounds are too large, they may not pass through the cell membrane, and their bioavailability would be affected; if they are too small, they would not retain to the (or proteins).

Scientists estimate that more than 80% of all known proteins associated with diseases cannot be targeted by conventional or antibody-based drugs. That is why, in recent years, cyclic peptides have become a very active research area. In principle, these compounds can achieve the fine balance required of modern drugs.

A cyclic peptide is a type of organic molecule that consists of amino acids linked together in a circular or lariat shape. What makes them particularly attractive is that they can target intracellular protein–protein interactions, which have been considered "undruggable" for decades. Moreover, cyclic peptides are inexpensive to synthesize compared to antibody-based drugs, prompting many pharmaceutical companies to conduct extensive research on these compounds.

However, one of the biggest hurdles to overcome in cyclic peptide research is that their membrane permeability—which controls their bioavailability and efficiency as drugs—is low in general, and the mechanisms behind this are not completely understood. Thus, during drug design, it is difficult for researchers to select candidate peptides that are likely to make it through the . On top of this, there are currently no openly accessible databases documenting the membrane permeabilities of known cyclic peptides.

A team of researchers from Tokyo Institute of Technology (Tokyo Tech), Japan, including Professor Yutaka Akiyama, decided to take a step towards making cyclic peptide research easier for everyone. As explained in their latest paper published in the Journal of Chemical Information and Modeling, the team created an online called CycPeptMPDB that contains information on thousands of cyclic peptides, including their membrane permeability.

To build the database, they gathered data from previously published papers and pharmaceutical patents. After inspecting more than 40 publications, they collected information on 7,334 cyclic peptides with widely different chemical structures. They loaded the membrane permeability values and important physical parameters such as lipophilicity of these peptides onto the database.

Moreover, to make further analysis and visualization of the molecules possible, the researchers calculated the most likely 3D conformation of each peptide and added it to the database. They also encoded the chemical structure of each cyclic peptide in a novel descriptive notation (called HELM), making it possible to unambiguously refer to any cyclic peptide in the database using a short string of text.

The team has high hopes for their platform and believe that it could become a game changer in the design and development of cyclic peptide drugs. "CycPeptMPDB provides several functions, including , statistics and visualization, searching and analysis, and downloading. We expect it will become a to support membrane permeability research on cyclic peptides," says Prof. Akiyama.

It is also worth noting, that databases such as CycPeptMPDB are essential for training machine learning models, which can accelerate the selection of drug candidates and reveal hidden patterns in the data.

"We will continue to collect permeability data of and record them in CycPeptMPDB. Additionally, future improvements to the database's online analysis platform will include an improved user-friendly interface and more integrative functions," says Prof. Akiyama.

More information: Jianan Li et al, CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides, Journal of Chemical Information and Modeling (2023). DOI: 10.1021/acs.jcim.2c01573

Citation: A novel database aimed at promoting drug design using cyclic peptides (2023, April 5) retrieved 3 October 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Investigating the effects of amide-to-ester substitutions on membrane permeability of cyclic peptides


Feedback to editors